1. Drug-induced interstitial lung disease (DILD) in molecular targeted therapy

   • Akihiko Gemma

   Introduction to Review Articles 15 November 2012 Pages: 533 - 533

2. Current status of DILD in molecular targeted therapies

   • Yoshinobu Saito
   • Akihiko Gemma

   Review Article 15 November 2012 Pages: 534 - 541

   

3. Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings

   • Fumikazu Sakai
   • Takeshi Johkoh
   • Masahiro Takahashi

   Review Article 10 November 2012 Pages: 542 - 550

   

4. IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas

   • Ichiyo Shibahara
   • Yukihiko Sonoda
   • Teiji Tominaga

   Original Article 06 October 2011 Pages: 551 - 561

   

5. Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer

   • Takashi Mizowaki
   • Kenji Takayama
   • Masahiro Hiraoka

   Original Article 05 October 2011 Pages: 562 - 568

   

6. Paget’s disease of the vulva: a clinicopathologic institutional review

   • Alberto A. Mendivil
   • Lisa Abaid
   • Bram H. Goldstein

   Original Article 01 October 2011 Pages: 569 - 574

   

7. Serum total oxidant/antioxidant status and trace element levels in breast cancer patients

   • Jia-Fu Feng
   • Ling Lu
   • Dong Wang

   Original Article 05 October 2011 Pages: 575 - 583

8. Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan

   • Chikashi Yoshida
   • Linda Fletcher
   • Hisashi Sakamaki

   Original Article 12 October 2011 Pages: 584 - 589

   

9. Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer

   • Taejong Song
   • Jeong-Won Lee
   • Byoung-Gie Kim

   Original Article 13 October 2011 Pages: 590 - 597

   

10. Sperm banking and assisted reproductive outcome in men with cancer: a 10 years’ experience

    • Thomas Freour
    • Sophie Mirallie
    • Paul Barriere

    Original Article 07 October 2011 Pages: 598 - 603

    

11. Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trial

    • Yosuke Horita
    • Yasuhide Yamada
    • Yasuhiro Shimada

    Original Article 15 October 2011 Pages: 604 - 609

    

12. Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC?

    • Yuki Nakajima
    • Sadamoto Zenda
    • Atsushi Ohtsu

    Original Article 27 October 2011 Pages: 610 - 615

    

13. List of reviewers 2011–2012

    Acknowledgments 14 December 2012 Pages: 616 - 617